Outcomes After Transcutaneous Bone-Conduction Implantation in Adults and Children.
Journal
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504
Informations de publication
Date de publication:
01 04 2023
01 04 2023
Historique:
pubmed:
28
1
2023
medline:
24
3
2023
entrez:
27
1
2023
Statut:
ppublish
Résumé
To evaluate clinical and audiometric outcomes of adult and pediatric patients implanted with a semi-implantable transcutaneous active bone-conduction implant. Retrospective chart review. Two tertiary referral centers. Subjects implanted with the semi-implantable transcutaneous active bone-conduction implant called BoneBridge. Implantation of the BoneBridge and audiometric evaluations. Audiometric, clinical, and surgical outcomes as well as complications. Forty-two adults and 20 children were implanted for conductive or mixed hearing loss as well as single-sided deafness. Implantation significantly improved mean air-conduction pure-tone average from 72.8 ± 22.3 to 35 ± 9 dB in adults and from 65.7 ± 24.3 to 19.6 ± 8.2 dB in children (both p < 0.001). Word recognition score improved from 63.7 ± 38.8% to 85.6 ± 10.6% in adults and 57.8 ± 38% to 89.3 ± 10.1% in children (both p < 0.05). The rate of revision surgery was 11.3%, with four patients (6.5%) undergoing removal for device-related complications, two (3.2%) for complications associated with implantation, and one (1.6%) for device failure secondary to external trauma. In a large retrospective series consisting of both pediatric and adult patients, implantation with a transcutaneous active bone-conduction implant was found to be a reliable aural rehabilitation option for a variety of hearing loss etiologies.
Identifiants
pubmed: 36706442
doi: 10.1097/MAO.0000000000003821
pii: 00129492-202304000-00004
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
317-323Informations de copyright
Copyright © 2023, Otology & Neurotology, Inc.
Déclaration de conflit d'intérêts
The authors disclose no conflicts of interest.
Références
Sprinzl GM, Wolf-Magele A. The BoneBridge bone conduction hearing implant: Indication criteria, surgery and a systematic review of the literature. Clin Otolaryngol 2016;41:131–43.
Beutner D, Delb W, Frenzel H, et al. Guideline “implantable hearing aids”—short version: German S2k guideline of the Working Group of German-speaking Audiologists, Neurootologists and Otologists (ADANO), of the German Society of Oto-Rhino-Laryngology, Head and Neck surgery (DGHNO) in collaboration with the German Society of Audiology (DGA), the German Society of Phoniatrics and Pediatric Audiology (DGPP), and patient representatives. HNO 2018;66:654–9.
Cywka KB, Skarzynski PH, Krol B, et al. Evaluation of the BoneBridge BCI 602 active bone conductive implant in adults: Efficacy and stability of audiological, surgical, and functional outcomes. Eur Arch Otorhinolaryngol 2022;279:3525–34.
Carnevale C, Til-Pérez G, Arancibia-Tagle DJ, et al. Hearing outcomes of the active bone conduction system BoneBridge® in conductive or mixed hearing loss. Acta Otorrinolaringol Esp (Engl Ed) 2019;70:80–8.
Seiwerth I, Fröhlich L, Schilde S, et al. Clinical and functional results after implantation of the BoneBridge, a semi-implantable, active transcutaneous bone conduction device, in children and adults. Eur Arch Otorhinolaryngol 2022;279:101–13.
Rahne T, Seiwerth I, Götze G, et al. Functional results after BoneBridge implantation in adults and children with conductive and mixed hearing loss. Eur Arch Otorhinolaryngol 2015;272:3263–9.
Oh SJ, Goh EK, Choi SW, et al. Audiologic, surgical and subjective outcomes of active transcutaneous bone conduction implant system (BoneBridge). Int J Audiol 2019;58:956–63.
Yang J, Chen P, Zhao C, et al. Audiological and subjective outcomes of 100 implanted transcutaneous bone conduction devices and preoperative bone conduction hearing aids in patients with bilateral microtia-atresia. Acta Otolaryngol 2020;140:675–81.
Wagner JH, Ernst A, Todt I. Magnet resonance imaging safety of the Vibrant Soundbridge system: a review. Otol Neurotol 2011;32:1040–6.
Brkic FF, Riss D, Scheuba K, et al. Medical, technical and audiological outcomes of hearing rehabilitation with the BoneBridge Transcutaneous bone-conduction implant: A single-center experience. J Clin Med 2019;8.
Gerdes T, Salcher RB, Schwab B, et al. Comparison of audiological results between a transcutaneous and a percutaneous bone conduction instrument in conductive hearing loss. Otol Neurotol 2016;37:685–91.
Sprinzl G, Lenarz T, Ernst A, et al. First European multicenter results with a new transcutaneous bone conduction hearing implant system: Short-term safety and efficacy. Otol Neurotol 2013;34:1076–83.
Stenfelt S. Transcranial attenuation of bone-conducted sound when stimulation is at the mastoid and at the bone conduction hearing aid position. Otol Neurotol 2012;33:105–14.
Eeg-Olofsson M, Stenfelt S, Tjellström A, et al. Transmission of bone-conducted sound in the human skull measured by cochlear vibrations. Int J Audiol 2008;47:761–9.
Huber AM, Sim JH, Xie YZ, et al. The BoneBridge: Preclinical evaluation of a new transcutaneously-activated bone anchored hearing device. Hear Res 2013;301:93–9.
Eeg-Olofsson M, Stenfelt S, Granström G. Implications for contralateral bone-conducted transmission as measured by cochlear vibrations. Otol Neurotol 2011;32:192–8.
Wimmer W, von Werdt M, Mantokoudis G, et al. Outcome prediction for BoneBridge candidates based on audiological indication criteria. Auris Nasus Larynx 2019;46:681–6.
Iseri M, Orhan KS, Tuncer U, et al. Transcutaneous bone-anchored hearing aids versus percutaneous ones: Multicenter comparative clinical study. Otol Neurotol 2015;36:849–53.
Hobson JC, Roper AJ, Andrew R, et al. Complications of bone-anchored hearing aid implantation. J Laryngol Otol 2010;124:132–6.
Kulasegarah J, Burgess H, Neeff M, et al. Comparing audiological outcomes between the BoneBridge and bone conduction hearing aid on a hard test band: Our experience in children with atresia and microtia. Int J Pediatr Otorhinolaryngol 2018;107:176–82.
Fan X, Yang T, Niu X, et al. Long-term outcomes of bone conduction hearing implants in patients with bilateral microtia-atresia. Otol Neurotol 2019;40:998–1005.
Bravo-Torres S, Der-Mussa C, Fuentes-López E. Active transcutaneous bone conduction implant: Audiological results in paediatric patients with bilateral microtia associated with external auditory canal atresia. Int J Audiol 2018;57:53–60.
Dimbleby G, Mitchell-Innes A, Murphy J. Peri-operative cerebrospinal fluid leak during single-stage bone-anchored hearing aid implantation: Case report. J Laryngol Otol 2014;128:1111–3.
Schmerber S, Deguine O, Marx M, et al. Safety and effectiveness of the BoneBridge transcutaneous active direct-drive bone-conduction hearing implant at 1-year device use. Eur Arch Otorhinolaryngol 2017;274:1835–51.
Ihler F, Volbers L, Blum J, et al. Preliminary functional results and quality of life after implantation of a new bone conduction hearing device in patients with conductive and mixed hearing loss. Otol Neurotol 2014;35:211–5.